Charles River Laboratories International, Inc. and Wheeler Bio, Inc. announced an agreement to implement RightSourceSM at Wheeler Bio’s current good manufacturing practice (CGMP) biologics manufacturing facility in Oklahoma City, OK. Deployed on-site at a client’s facility, RightSourceSM is a flexible biologics testing lab operated and managed by Charles River, making fast, reliable quality control (QC) more accessible to a broader reach of companies.
Through this model, Charles River, in close collaboration with Wheeler, will set up a CGMP testing lab, on-site at Wheeler’s facility. This platform-based satellite lab will be operated by Charles River employees who will utilize Charles River’s quality management systems, test methods, and standard operating procedures (SOPs) to support all QC testing needs for Wheeler and its third-party clients.
The RightSourceSM platform is a novel insourcing solution serving biotech and biopharmaceutical companies with the panel of assays they deem necessary for their biologics manufacturing program to have on site. Unlike standard staffing solutions, RightSourceSM offers clients the expertise to bring Charles River’s proprietary assays in-house, with the same quality and scientific platforms used at Charles River’s outsourcing facilities. Having a RightSourceSM program in-house enables clients to leverage Charles River’s wider network of regulatory, scientific consultation and biologics testing support, and will deliver rapid turnaround times and expedited batch release on behalf of Wheeler’s clients.
As Charles River continues investing in digitalization, all RightSourceSM clients will automatically receive enhanced products and services, increasing the value of the partnership as time goes on. The RightSourceSM laboratory at Wheeler Bio will be operational in the third quarter of 2023 and is anticipated to start in-process and release testing by the end of the year.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox!
Sign up now!